Dong-A looks forward to achieving the top pharmaceutical company with its 4 new drugs

Published: 2015-04-21 14:30:57

Updated: 2015-04-21 14:30:57

The Dong-A ST’s constant R&D investment and effort launched the 24^th domestic new drug.

Dong-A ST (CEO and President Chan-il Park) announced on the 17^th that its first FDA-approve super bacteria antibiotic ‘Sivextro (generic name: tedizolid)’ has been approved for a domestic new drug from the Ministry of Food and Drug Safety.

Dong-A ST started to develop Sivextro in 2004 and completed the ent...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.